Immunotherapy Using Immunogenic Mimotopes Selected by Phage Display plus Amphotericin B Inducing a Therapeutic Response in Mice Infected with Leishmania amazonensis

Leishmania amazonensis can cause cutaneous and visceral clinical manifestations of leishmaniasis in infected hosts. Once the treatment against disease is toxic, presents high cost, and/or there is the emergence of parasite-resistant strains, alternative means through which to control the disease mus...

Descripción completa

Detalles Bibliográficos
Autores principales: Soyer, Tauane G., Ramos, Fernanda F., Pereira, Isabela A. G., Lage, Daniela P., Bandeira, Raquel S., de Jesus, Marcelo M., Costa, Guilherme P., Machado, Amanda S., Freitas, Camila S., Vale, Danniele L., Martins, Vívian T., Galdino, Alexsandro S., Chávez-Fumagalli, Miguel A., Menezes-Souza, Daniel, Duarte, Mariana C., Roatt, Bruno M., Coelho, Eduardo A. F., Tavares, Grasiele S. V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9964457/
https://www.ncbi.nlm.nih.gov/pubmed/36839586
http://dx.doi.org/10.3390/pathogens12020314

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9964457/
https://www.ncbi.nlm.nih.gov/pubmed/36839586
http://dx.doi.org/10.3390/pathogens12020314

Ejemplares similares